BAFNA PHARMACEUTICALS IPO WILL HITT THE MARKET ON 27-05-2008 FIX PRISE @40Rs SHARES 6500000.................................SHRE OPINION ALL FRIENDS......... I WILL GO FOR IT................
niraj cement structural IPO will play momentum activity after listing because nearly 5%(5,oo,ooo share)are held by NIRMAL KOTECHA.who is well known as BULL OPERATER.
31.03.2007 (Unaudited) ) Income from Operations 7,997.04 Expenditure: a. (Increase ) Decrease in stock in trade b. Consumption of Raw Materials 6,319.42 c. Staff Cost 108.91 d. Other Expenditure 184.89 Profit before interest, Depreciation and Tax Interest 131.03 Depreciation 83.31 Profit before Tax 866.77 Provision For Current Tax 95.35 Provision For Deferred Tax 83.93 Provision For Fringe Benefit Tax Prior Period Items Deferred Revenue Expenditure Profit after Tax 771.43 Paid up Equity Share Capital 709.28 Reserves excluding revaluation reserves 3,467.34 Basic & diluted earnings per share 70.93
Hi, solanki, Niraj is not an exciting issue. It may not give good gains. The industry is not fancied now. JKIL, GammonInfra have not given any good returns. One has to be careful with this issue. Moreover,the issue is priced at a PE of morethan 20.
1. Niraj has history of cheque dishonors & bank loan defaults.
2. Application for listing on NSE withdrawn "to hasten IPO process" !!!
3. CARE IPO Grade 1.
4. 70.94 (5032.03 - Net Worth divided by 70.928 equity shares) is pre-IPO "BOOK VALUE", and not EPS. Book value post IPO is 5032.03/103.428 = 48.65. Niraj's website misrepresents figures. Post issue P/B = 3.9
5. PAT for 2008 was 652.62 lacks (declining from 779.49 in 2006). Pre IPO EPS is 652.62/70.928 = 9.2. Post IPO EPS = 652.62/103.428 = 6.3. Post issue PE = 30 - Very High for a small co.
6. Original issue period was 26th to 29th May. They have changed it to 22nd to 28th May, presumably because of "not very enthusiastic" response to other infra IPOs in recent past.